Agonists |
|
Cat. No. | Product Name / Activity |
---|---|
3492 | ACTH (1-39) |
Potent endogenous MC2 agonist | |
2566 | Melanotan II |
High affinity melanocortin receptor agonist | |
3424 | γ1-MSH |
Selective MC3 receptor agonist | |
4272 | [D-Trp8]-γ-MSH |
Selective MC3 receptor agonist | |
3013 | [Nle4,D-Phe7]-α-MSH |
Melanocortin receptor agonist | |
2584 | α-MSH |
Endogenous melanocortin receptor agonist | |
5094 | PG 931 |
Potent and selective MC4 receptor agonist | |
Antagonists |
|
Cat. No. | Product Name / Activity |
1831 | HS 014 |
Selective MC4 receptor antagonist | |
1832 | HS 024 |
Highly potent MC4 receptor antagonist | |
3426 | JKC 363 |
Potent and selective MC4 receptor antagonist | |
3438 | MCL 0020 |
Selective MC4 receptor antagonist | |
5954 | MSG 606 |
Potent human MC1 receptor antagonist; also MC3 and MC5 partial agonist | |
4919 | PG 106 |
Selective MC3 receptor antagonist | |
Other |
|
Cat. No. | Product Name / Activity |
3611 | Lys-γ3-MSH |
Pro-opiomelanocortin (POMC) derived peptide | |
1929 | Melanocyte-stimulating hormone release inhibiting factor |
Inhibitor of α-MSH release; inhibits opioid effects in vivo | |
3420 | SHU 9119 |
MC3 and MC4 antagonist; MC5 partial agonist |